Good evening :)
Place Order
Add to Watchlist

Advanced Enzyme Technologies Ltd

ADVENZYMES

Advanced Enzyme Technologies Ltd

ADVENZYMES
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹5,453 cr, stock is ranked 749
Moderate RiskStock is 2.70x as volatile as Nifty
484.950.50% (-2.45)
484.950.50% (-2.45)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹5,453 cr, stock is ranked 749
Moderate RiskStock is 2.70x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹5,453 cr, stock is ranked 749
Moderate RiskStock is 2.70x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
39.333.981.05%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
32.123.661.16%

Forecast & Ratings

Detailed Forecast 
0%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Advanced Enzyme Technologies is engaged in the research and development, manufacturing and marketing of over 400 products developed from over 60 indigenous enzymes.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 9.24%, vs industry avg of 6.09%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.77% to 0.79%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 3.72%, vs industry avg of -1.55%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue295.05331.57392.41424.63449.63510.69535.80566.10660.53668.10
Raw Materialssubtract69.6670.1480.3365.9590.83100.21130.32127.53155.47434.64
Power & Fuel Costsubtract10.1712.8718.1019.2919.3721.4529.9538.1040.92
Employee Costsubtract44.5050.7068.6080.2380.1987.11103.96114.80128.37
Selling & Administrative Expensessubtract23.5025.6138.4140.0437.5837.7251.8056.2260.11
Operating & Other expensessubtract12.4718.0020.6430.8412.6522.7810.7750.5648.48
Depreciation/Amortizationsubtract8.7212.7618.3021.1225.7828.7234.9835.0335.2435.22
Interest & Other Itemssubtract7.864.439.065.204.082.572.963.484.123.15
Taxes & Other Itemssubtract42.3445.5148.9150.9049.8764.2151.4834.7554.5256.45
EPS1.392.798.079.9511.5813.0610.709.4511.9212.40
DPS0.200.080.500.600.600.901.001.005.105.00
Payout ratio0.140.030.060.060.050.070.090.110.430.40

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

May 20PDF
Feb 5PDF
Nov 2PDF
+2 more
FY 2023

Annual report

PDF

Investor Presentation

May 13PDF
Feb 11PDF
Nov 11PDF
Aug 6PDF
FY 2024

Annual report

PDF

Investor Presentation

Aug 12PDF
 

Peers & Comparison

Comparing 3 stocks from 
MaterialsSpecialty Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Advanced Enzyme Technologies Ltd40.913.981.05%
Gujarat Fluorochemicals Ltd117.688.62—
Vinati Organics Ltd63.098.280.36%
Akzo Nobel India Ltd44.9714.421.54%

Price Comparison

Compare ADVENZYMES with any stock or ETF
Compare ADVENZYMES with any stock or ETF
ADVENZYMES
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Decreased Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has decreased by 10.98%

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding43.02%5.82%2.27%12.03%36.87%

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Shareholding History

MarJunSepDec '23MarJun21.86%21.90%22.27%22.54%23.01%12.03%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Advanced Enzyme Technologies Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
HDFC Small Cap Fund - Growth - Direct Plan

Growth
2.6198%0.42%0.03%36/92 (+3)
UTI AMC LTD # UTI MF-UTI MNC FUND DIRECT PLAN GROWTH PLAN GROWTH

Growth
0.8926%1.55%0.32%27/50 (+6)
ICICI Prudential ESG Exclusionary Strategy Fund - Growth - Direct Plan

Growth
0.8172%2.72%0.17%12/48 (0)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividend Cuts

Dividends are the portion of earnings that a company distributes to all its shareholders every year

ADVENZYMES has increased or maintained dividend levels over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 1.04%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹10.36 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJul 18, 2024

Final
Final | Div/Share: ₹1.10

Dividend/Share

₹1.10

Ex DateEx Date

Jul 18, 2024

Cash Dividend

Ex DateEx DateMay 17, 2024

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

₹4.00

Ex DateEx Date

May 17, 2024

Cash Dividend

Ex DateEx DateAug 4, 2023

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Aug 4, 2023

Cash Dividend

Ex DateEx DateMay 19, 2023

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

₹4.00

Ex DateEx Date

May 19, 2023

Cash Dividend

Ex DateEx DateAug 11, 2022

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Aug 11, 2022

News & Opinions
Earnings
Advanced Enzyme Technologies consolidated net profit rises 18.54% in the June 2024 quarter

Net profit of Advanced Enzyme Technologies rose 18.54% to Rs 34.15 crore in the quarter ended June 2024 as against Rs 28.81 crore during the previous quarter ended June 2023. Sales rose 4.92% to Rs 154.52 crore in the quarter ended June 2024 as against Rs 147.28 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales154.52147.28 5 OPM %33.1229.89 - PBDT57.2950.04 14 PBT48.6741.41 18 NP34.1528.81 19 Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Advanced Enzyme Techs. announces board meeting date

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 10 August 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live

Stock alert: Indus Towers, Gland Pharma, Advanced Enzyme, DMart, Sapphire Foods

3 months agoBusiness Standard

Motilal Oswal Buys Shares Of Advanced Enzyme Technologies For Rs 425.5 Crore

3 months agoBloomberg Quint

Advanced Enzyme jumps 4% as ICICI Mutual Fund acquires stake

1 year agoMoneycontrol

Advanced Enzyme Technologies Ltd Spurts 2.63%

1 year agoBusiness Standard

Stocks To Watch: Reliance Industries, Advanced Enzyme, NTPC, Themis Medicare

1 year agoBloomberg Quint

Has RBL Bank reversed its trend?

1 year agoThe Hindu Businessline

Advanced Enzyme, Cummins India, TCI & KEC International: Here’s what analysts say

1 year agoBusiness Today

Hold Advanced Enzyme Technologies; target of Rs 300: ICICI Direct

1 year agoMoneycontrol